Rbf Capital, LLC Vascular Biogenics Ltd. Transaction History

Rbf Capital, LLC

  • $1.71 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$1.16 - $1.53 $161,146 - $212,546
-138,919 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$0.94 - $1.75 $211,316 - $393,408
-224,805 Reduced 61.81%
138,919 $211,000
Q4 2018

Feb 14, 2019
BUY
$0.6 - $1.72 $218,234 - $625,605
363,724 New
363,724 $353,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Rbf Capital, LLC Portfolio

Follow Rbf Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbf Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email